CANO

Cano Health Announces Date to Report Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 1, 2023
Conference, CANO, NYSE, Webcast, Rare-earth element, Shipbuilding

MIAMI, Nov. 1, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the third quarter 2023 after the market closes on Thursday, November 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.

Key Points: 
  • MIAMI, Nov. 1, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the third quarter 2023 after the market closes on Thursday, November 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Third Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Cano Health Announces Change in Chief Financial Officer Role

Retrieved on: 
Friday, September 29, 2023
Interim, Florida International University, Professional, Frankfurt School of Finance & Management, Blue Cross Blue Shield Association, History of Florida International University, Humana, Certification, Medicare, Eladio, Interim management, Secretary of State of Florida, School, CPA, CANO, CFO, NYSE, Management

MIAMI, Sept. 29, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023. Mr. Gil, who previously served as Cano Health's Vice President of Medicare Advantage Finance, succeeds Brian Koppy, who has stepped down to accept an opportunity outside the organization.

Key Points: 
  • MIAMI, Sept. 29, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023.
  • Before joining Cano Health, Mr. Gil served as the Chief Financial Officer of Total Health, where he managed the company's finance and accounting functions, as well as Management Services Organizations Operations.
  • Additionally, he has held key finance and business leadership roles with other major healthcare companies, including as Chief Financial Officer of CarePlus Health and as Vice President of Care Delivery with Humana.
  • "We are thrilled to welcome Eladio as Interim CFO," said Mark Kent, Chief Executive Officer of Cano Health.

Cano Health sells substantially all of its Primary Care Centers in Texas & Nevada to CenterWell Senior Primary Care

Retrieved on: 
Tuesday, September 26, 2023
CANO, Borrowing base, Sale, Patient, NYSE, Credit Suisse, Bank

MIAMI, Sept. 26, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell").

Key Points: 
  • MIAMI, Sept. 26, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell").
  • As of August 1, 2023, the primary care centers in Texas and Nevada cared for approximately 15,200 members.
  • We appreciate CenterWell recognizing the value that Cano Health created in Texas and Nevada and look forward to them continuing to deliver high quality care for our patients there."
  • Following the transaction, Cano Health has available liquidity consisting of approximately $109 million of unrestricted cash.

Cano Health Reschedules Second Quarter 2023 Earnings Conference Call

Retrieved on: 
Wednesday, August 9, 2023
CANO, Webcast, Conference, NYSE, Rare-earth element, Shipbuilding

MIAMI, Aug. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), announced today that it has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon.

Key Points: 
  • MIAMI, Aug. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), announced today that it has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Second Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Cano Health Announces Date to Report Second Quarter 2023 Results

Retrieved on: 
Tuesday, July 25, 2023
CANO, Webcast, Conference, NYSE, Oyster farming, Shipbuilding

MIAMI, July 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the second quarter 2023 after the market closes on Wednesday, August 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.

Key Points: 
  • MIAMI, July 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the second quarter 2023 after the market closes on Wednesday, August 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Second Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call.

Concerned Shareholders of Cano Health Condemn the Board’s Egregious Conduct and Unwillingness to Accept a Resounding Rebuke at the 2023 Annual Meeting

Retrieved on: 
Monday, July 17, 2023
Finance, Other Health, Health, Professional Services, Other Professional Services, Executive, Employment, Face, Public opinion, Disclosure, Annual Meetings of the International Monetary Fund and the World Bank Group, Russell 3000 Index, Million Pound Menu, 2021 Libertarian National Committee chair special election, Audit committee, MSP, Committee, Council of Institutional Investors, Russell, Hearing, Council, Annual general meeting, CANO, Ethics, Rivera, NYSE, Weil, Gotshal & Manges, Compensated emancipation, Holding company, Management, Security (finance), Shareholder

The three of us hold an approximately 35% equity stake in Cano, making our Group the largest stockholder of the Company.

Key Points: 
  • The three of us hold an approximately 35% equity stake in Cano, making our Group the largest stockholder of the Company.
  • We encourage Mark Kent, Cano’s interim Chief Executive Officer, and his team to focus on achieving efficiencies, eliminating excesses and executing a more focused strategy.
  • The Board has disregarded the unambiguous results of the Annual Meeting, where more than 82% of the votes cast WITHHELD support for Dr. Alan Muney and Kim Rivera.
  • The Board continues to keep in place Sol Trujillo as Chairman and Angel Morales as Chair of the Audit Committee.

Concerned Shareholders of Cano Health Address Company’s Offensive Friday Afternoon “News Dump” Regarding its Leadership Transition

Retrieved on: 
Tuesday, June 20, 2023
Banking, Professional Services, Finance, Executive, Employment, Face, History, CANO, NYSE, Management, Holding company, Corporate America, Shareholder

But Mr. Kent and his management team need a credible, confidence-inspiring Board behind them to initiate a lasting turnaround at Cano.

Key Points: 
  • But Mr. Kent and his management team need a credible, confidence-inspiring Board behind them to initiate a lasting turnaround at Cano.
  • The current Board, half of which is composed of two WITHHOLD directors and the beleaguered ex-CEO, is simply not equipped to effectively oversee Cano at this critical juncture.
  • The Board’s so-called independent members remain insufficiently aligned with the stockholders who actually own the vast majority of Cano.
  • In the meantime, we will continue to use all available channels to hold Cano’s insiders accountable to stockholders.”
    View source version on businesswire.com: https://www.businesswire.com/news/home/20230619285745/en/

Concerned Shareholders of Cano Health Obtain Clear Referendum for Change at 2023 Annual Meeting

Retrieved on: 
Friday, June 16, 2023
Consulting, Professional Services, Finance, CANO, Policy, Annual Meetings of the International Monetary Fund and the World Bank Group, Annual general meeting, NYSE, Compensated emancipation, Holding company, Shareholder

“We thank our fellow stockholders for the outpouring of encouragement and support during this initial stage of our campaign to turn around Cano.

Key Points: 
  • “We thank our fellow stockholders for the outpouring of encouragement and support during this initial stage of our campaign to turn around Cano.
  • The outcome of the Annual Meeting, whereat more than 75% of the votes cast WITHHELD support for the directors up for re-election, represents a clear and striking referendum on the failures of Cano’s leadership.
  • Unfortunately, the only party in denial about the need for sweeping changes appears to be the current Board.
  • Regardless of the Board’s apparent disdain for stockholders’ feedback, we will continue to pursue change through all available means until Dr. Marlow Hernandez, Sol Trujillo and other misaligned directors are no longer affiliated with the Company.”
    View source version on businesswire.com: https://www.businesswire.com/news/home/20230616019122/en/

Concerned Shareholders of Cano Health Reiterate the Need for Changes in Leadership and Strategy at the Company Following Massive Value Destruction

Retrieved on: 
Wednesday, June 14, 2023
Consulting, Professional Services, Finance, GREEN, 2015 Michigan Proposal 1, Disclosure, Annual Meetings of the International Monetary Fund and the World Bank Group, Delaware Court, Annual general meeting, CANO, Court, Delaware Court of Chancery, NYSE, Shareholder

It is critically important that this shared desire for urgent change translates to resounding WITHHOLD votes for the two directors standing for election at tomorrow’s Annual Meeting.

Key Points: 
  • It is critically important that this shared desire for urgent change translates to resounding WITHHOLD votes for the two directors standing for election at tomorrow’s Annual Meeting.
  • We, as stockholders, cannot afford to continue to rely on the same leadership that has presided over abysmal capital allocation, dismal corporate governance and disclosure practices, and disastrous strategic decisions.
  • The stakes are far too high now that Cano has burned through more than a billion dollars in cash and seen its stock price plunge approximately 90%.
  • We sincerely hope that the Board and leadership take to heart our desire – shared by many stockholders – for increased integrity and accountability.

ISS and Glass Lewis Recommend Cano Health Stockholders WITHHOLD on Incumbent Directors Dr. Alan Muney and Kim Rivera

Retrieved on: 
Wednesday, June 7, 2023
Professional Services, Finance, GREEN, Shalva Weil, Dissident, 2015 Michigan Proposal 1, Annual Meetings of the International Monetary Fund and the World Bank Group, Delaware Court, Strategic planning, Glass Lewis, Annual general meeting, CANO, Delaware Court of Chancery, Glass, NYSE, ISS, Management, Security (finance), Pharmaceutical industry, Shareholder

“We appreciate that ISS and Glass Lewis have validated our campaign for boardroom change by recommending stockholders withhold their support for Dr. Muney and Ms. Rivera at the upcoming Annual Meeting.

Key Points: 
  • “We appreciate that ISS and Glass Lewis have validated our campaign for boardroom change by recommending stockholders withhold their support for Dr. Muney and Ms. Rivera at the upcoming Annual Meeting.
  • We believe that Dr. Muney and Ms. Rivera bear direct responsibility for many recent anti-stockholder actions given their roles leading key committees.
  • The effort to create the special committee was spearheaded by Muney and Rivera.
  • We urge stockholders to vote WITHHOLD on Proposal 1, the election of Dr. Muney and Ms. Rivera, on any proxy card received (the GREEN or WHITE proxy card).